BRAND PORTFOLIO

You are here:
  • Neuropsychiatry

    Ultramate

    Topiramate

    Ultramate (Topiramate) is an anti-epileptic drug used to manage seizures and prevent migraines. It was initially approved by the FDA in 1996. In 2004, topiramate was approved for the prevention of migraine in adults. Characteristics that distinguish topiramate from other antiepileptic drugs are a monosaccharide chemical structure containing a sulfamate, and 40% of its mass…

    Know More
  • Renal Care

    Ultraniche-T

    Tapentadol

    Tapentadol is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain. Tapentadol extended-release tablets are used to treat severe neuropathic pain (pain caused by nerve damage) in people who have diabetes. Tapentadol is an orally available, synthetic benzenoid that acts as…

    Know More
  • Skinceuticals

    Ultrawyte

    Glutathione, Vitamin C, Vitamin E / L-Glutathione, Vitamin C / Lyophilized Glutathione

    ULTRAWYTE is the brand of Glutathione which is a physiological tripeptide, a chain of three amino acid- cysteine, glycine and glutamic acid. It is used for the detoxification of electrophilic metabolites. It is a very efficient free radical scavenger, preventing damage to important cellular components caused by reactive oxygen species such as free radicals and…

    Know More
  • Skinceuticals

    UV Hold

    Ethylexyl Methoxycinnamate + Benzophenone + Butyl Methoxydibenzol-methane + Titanium Dioxide + Micronized Zinc Oxide + Phospholipids + 1, 3-Butylene Glycol

    UV Hold is a new scientifically formulated sunscreen with SPF 30 for better protection of skin from harmful radiations coming from sun which otherwise may cause cancer to skin.

    Know More
  • Renal Care

    Valniche

    Valganciclovir

    Valniche is an antiviral medication used to treat cytomegalovirus infections. After oral administration, it is rapidly converted to ganciclovir by intestinal and hepatic esterase

    Know More
  • Critical Care

    VANCOPRO

    Vancomycin

    Vancomycin is a glycopeptide antibiotic. Approved by FDA on January 29, 2018. Active against most strains of the microorganisms, both in vitro and in clinical infections. The mean elimination half-life of vancomycin from plasma is 4 to 6 hours in subjects with normal renal function. Vancomycin is approximately 55% serum protein-bound. It has a rapid…

    Know More